Skip to main content
Premium Trial:

Request an Annual Quote

Ford Kennedy, John Josef Molenda, Alan D. Lourie

Premium
ITI Life Sciences, a Scottish entrepreneurial innovation fund, last week said that it has appointed Ford Kennedy as director of commercialization.
 
Kennedy’s role at ITI Life Sciences is to identify commercial opportunities and secure licenses for its portfolio of new technologies and intellectual property resulting from ITI research programs. Most recently, he served as director of scientific sourcing and new technologies at Millipore.
 

 
John Josef Molenda has joined Jenner & Block's New York office as of counsel in the firm's intellectual property and appellate and supreme court practices.
 
Most recently, Molenda was an associate at Frommer Lawrence & Haug LLP, where he concentrated his practice in chemical, pharmaceutical, and biotech patent litigation.
 
Molenda has a PhD in chemistry from Vanderbilt University, and conducted post-doctoral research in DNA topology at New York University. He holds a JD from the University of Michigan, and served as a judicial law clerk to the Honorable Alan D. Lourie, United States Court of Appeals for the Federal Circuit, from 1998 to 2000.
 

Molenda has litigation experience in a wide range of technologies, including drug development, genetic engineering, biochemistry, chemical compositions and material science, Jenner & Block said.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.